» Articles » PMID: 36670480

Functional Testing, Coronary Artery Calcifications, and Outcomes in Hodgkin Lymphoma Survivors Treated with Chest Radiation

Overview
Journal Cardiooncology
Publisher Biomed Central
Specialty Oncology
Date 2023 Jan 20
PMID 36670480
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Consensus guidelines recommend periodic screening for coronary artery disease (CAD) in Hodgkin lymphoma (HL) survivors treated with radiation therapy (RT) to the chest. However, the prognostic utility of screening strategies in this population remains unclear. We evaluated the association between functional testing, coronary artery calcifications (CAC), and guideline-based risk assessment and major adverse cardiovascular events (MACE) in HL survivors treated with RT.

Methods: We retrospectively studied HL survivors treated with RT who underwent functional testing between 2003 and 2020 and chest computed tomography (CT) within 12 months of each other at our center. CAC was assessed semi-quantitatively from CT images. Cardiovascular risk was estimated using the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Diagnostic test characteristics were calculated using major adverse cardiac events (MACE) during follow-up as the gold standard.

Results: The study included 159 patients (median age at functional testing 48 years, median age at HL diagnosis 27 years, 62.9% female). Abnormal functional testing had the highest specificity (94.2% (95% CI 88.4%-97.6%)) and positive likelihood ratio (4.55 (95% CI 1.86-11.13)) while CAC had the highest sensitivity (63.2% (95% CI 46.0%-78.2%)) and lowest negative likelihood ratio (0.52 (95% CI 0.34-0.80)). Specificity for ACC/AHA risk assessment was also high (88.5% (95% CI 81.1%-93.7%)). Over 3.3 years of follow-up, abnormal functional testing (adjusted subdistribution hazard ratio (SHR) 5.10, 95% CI 2.41 - 10.78, p < 0.001) and CAC (adjusted SHR 3.58, 95% CI 1.35 - 9.47, p = 0.010) were both significantly associated with MACE.

Conclusions: In HL survivors treated with RT, both abnormal functional testing and ACC/AHA risk assessment had high specificity for subsequent MACE, but CAC had higher sensitivity. Further research is needed to inform CAD screening and primary prevention strategies in this population.

Citing Articles

Effects of home-based exercise with telehealth guidance in lymphoma cancer survivors entering cardio-oncology rehabilitation: rationale and design of the tele@home study.

Chamradova K, Batalik L, Winnige P, Dosbaba F, Hartman M, Batalikova K Cardiooncology. 2024; 10(1):46.

PMID: 39080734 PMC: 11289918. DOI: 10.1186/s40959-024-00249-7.

References
1.
Chow E, Chen Y, Hudson M, Feijen E, Kremer L, Border W . Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. J Clin Oncol. 2017; 36(1):44-52. PMC: 5756324. DOI: 10.1200/JCO.2017.74.8673. View

2.
Divakaran S, Biery D, Berman A, Singh A, Hainer J, Wu W . Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma: The YOUNG-MI Registry. JACC CardioOncol. 2021; 3(2):319-321. PMC: 8352268. DOI: 10.1016/j.jaccao.2021.04.001. View

3.
Desiderio M, Lundbye J, Baker W, Farrell M, Jerome S, Heller G . Current Status of Patient Radiation Exposure of Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging. Circ Cardiovasc Imaging. 2018; 11(12):e007565. DOI: 10.1161/CIRCIMAGING.118.007565. View

4.
Lancellotti P, Nkomo V, Badano L, Bergler-Klein J, Bogaert J, Davin L . Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013; 14(8):721-40. DOI: 10.1093/ehjci/jet123. View

5.
Bolin E, Lam W . A review of sensitivity, specificity, and likelihood ratios: evaluating the utility of the electrocardiogram as a screening tool in hypertrophic cardiomyopathy. Congenit Heart Dis. 2013; 8(5):406-10. DOI: 10.1111/chd.12083. View